Phedias Diamandis, MD, PhD, FRCPC

Follow Dr. Diamandis:

Dr. Diamandis' research program aims to develop novel global molecular profiling technologies to study brain tumours, neurodevelopment and cancer stem cells.

Neurol Clin. 2018 Aug;36(3):439-447
Diamandis P, Aldape K
NPJ Precis Oncol. 2017;1(1):22
Djuric U, Zadeh G, Aldape K, Diamandis P
BMC Bioinformatics. 2018 May 16;19(1):173
Faust K, Xie Q, Han D, Goyle K, Volynskaya Z, Djuric U, Diamandis P
Mol Cell Proteomics. 2017 Sep;16(9):1548-1562
Djuric U, Rodrigues DC, Batruch I, Ellis J, Shannon P, Diamandis P
J Clin Oncol. 2017 Jul 20;35(21):2386-2393
Diamandis P, Aldape KD
Brain Dev. 2017 Jan;39(1):23-39
Diamandis P, Chitayat D, Toi A, Blaser S, Shannon P
Neuromuscul Disord. 2016 Mar;26(3):201-6
Bamaga AK, Riazi S, Amburgey K, Ong S, Halliday W, Diamandis P, Guerguerian AM, Dowling JJ, Yoon G
Diagn Pathol. 2016 Jan 27;11:13
Diamandis P, Ferrer-Luna R, Huang RY, Folkerth RD, Ligon AH, Wen PY, Beroukhim R, Ligon KL, Ramkissoon SH
Childs Nerv Syst. 2015 Oct;31(10):1699-706
Thompson YY, Ramaswamy V, Diamandis P, Daniels C, Taylor MD
Brain Pathol. 2014 Jan;24(1):101-2
Diamandis P, Amato D, Finkelstein J, Keith J

Pages


Neuropathologist, Department of Pathology, University Health Network
Assistant Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto